IBO (Impact BioMedical, Inc.) Stock Analysis - Analyst Ratings

Impact BioMedical, Inc. (IBO) is a publicly traded Healthcare sector company. As of May 21, 2026, IBO trades at $0.53 with a market cap of $58.04M and a P/E ratio of -1.52. IBO moved +4.03% today. Year to date, IBO is +3.30%; over the trailing twelve months it is -3.03%. Its 52-week range spans $0.36 to $6.17. Rallies surfaces IBO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate IBO?

The average price target is $0.00.

IBO Key Metrics

Key financial metrics for IBO
MetricValue
Price$0.53
Market Cap$58.04M
P/E Ratio-1.52
EPS$-0.38
Dividend Yield0.00%
52-Week High$6.17
52-Week Low$0.36
Volume839
Avg Volume0
Revenue (TTM)$0
Net Income$-11.87M
Gross Margin0.00%

IBO Analyst Consensus

IBO analyst coverage data. Average price target: $0.00.

Latest IBO News

Recent IBO Insider Trades

  • Macko Todd D sold 43.40K (~$24.37K) on Mar 27, 2026.
  • Macko Todd D sold 1.60K (~$961.28) on Mar 25, 2026.
  • Grady Jason sold 50.00K (~$32.51K) on Mar 23, 2026.

Common questions about IBO

What do analysts rate IBO?
The average price target is $0.00.
Does Rallies show IBO price targets?
Yes. Rallies tracks IBO analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is IBO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBO. It does not provide personalized investment advice.
IBO

IBO